Get started
Author

M. Rezai

Predictive biological markers for response of invasive breast cancer to anthracycline/cyclophosphamide-based primary (radio-)chemotherapy.
2005 · Hans-Bernd Prisack, Christiaan Karreman, et al. · PubMed · 41
Neoadjuvant treatment of HER2 overexpressing primary breast cancer with trastuzumab given concomitantly to epirubicin/ cyclophosphamide followed by docetaxel ± capecitabine. First analysis of efficacy and safety of the GBG/AGO multicenter intergroup-study “GeparQuattro”
2008 · M. Untch, M. Rezai, et al. · European Journal of Cancer Supplements · 27
Neoadjuvant bevacizumab and anthracycline–taxane-based chemotherapry in 686 triple-negative primary breast cancers: Seconday endpoint analysis of the GeparQuinto study (GBG 44).
2011 · B. Gerber, H. Eidtmann, et al. · Journal of Clinical Oncology · 23
S3-6: Neoadjuvant Chemotherapy of Paclitaxel with or without Rad001: Results of the Non-Responder Part of the GEPARQUINTO Study (GBG 44).
2011 · J Huober, C Hanusch, et al. · Cancer Research · 7
Capecitabine given concomitantly or in sequence with EC → docetaxel as neoadjuvant treatment for early breast cancer: GeparQuattro – a GBG/AGO intergroup-study
2008 · G. von Minckwitz, M. Rezai, et al. · European Journal of Cancer Supplements · 4
Efficiency of controlled cryotherapy in prevention of chemotherapy induced peripheral neuropathy (CIPN)
2019 · T. Schaper, M. Rezai, et al. · Annals of Oncology · 2
RNA-based molecular tumor typing and immunological infiltrate as response predictors to neoadjuvant chemotherapy: Prospective validation in the GeparQuinto-PREDICT substudy.
2011 · C. Denkert, R. Kronenwett, et al. · Journal of Clinical Oncology · 2
Axillary Sonography in Preoperative Staging of Breast Cancer
2015 · U. Nitz, R. Kuner, et al. · KARGER eBooks · 1
P3-14-13: A Prospective Open-Label Randomized Phase II Neoadjuvant Study of Non-Pegylated Liposomal Doxorubicin (MYOCET®) Plus Cyclophosphamide and Trastuzumab Versus Conventional Doxorubicin Plus Cyclophosphamide Alone, Each Followed by Docetaxel and Trastuzumab, in HER2−Positive Breast Cancer Patients.
2011 · A Llombart-Cussac, S Pernas-Simon, et al. · Cancer Research · 1
Results of Neoteam: A randomized multicenter phase II study of liposomal doxorubicin hydrochloride + trastuzumab vs conventional doxorubicin both in combination with cyclophosphamide and followed by docetaxel + trastuzumab as neoadjuvant treatment of HER2-positive primary breast cancer
2016 · S. Pernas Simon, M. Rezai, et al. · Annals of Oncology
PDF
Serum carbonic anhydrase IX as predictive marker for efficacy of bevacizumab: a biomarker analysis from the GeparQuinto phase III neoadjuvant breast cancer trial
2016 · Melanie Janning, E. Müller, et al.
Bevacizumab in der Brustkrebstherapie – Management schwerer Wundheilungsstörungen
2012 · C Nestle-Krämling, S Haack, et al. · Geburtshilfe und Frauenheilkunde
588 Why Some Surgeons Omit Sentinel Node Biopsy in Breast Cancer Patients? Barriers to Popularize Sentinel Node Biopsy in Low Resource Areas
2012 · N. Alavi, M. Ebrahimi, et al. · European Journal of Cancer
Relevanz zirkulierende Tumorzellen (CTCs) vor und nach adjuvanter Chemotherapie – Ergebnisse der SUCCESS-Studie
2010 · B Rack, C Schindlbeck, et al. · Senologie - Zeitschrift für Mammadiagnostik und -therapie
Free methylated DNA in association of clinical signs and circulating blood tumor cells in patients with breast cancer.
2010 · C. Matuschek, E. Boelke, et al. · Journal of Clinical Oncology
Bildgebung bei Patientinnen mit Brustimplantaten – Ergebnisse der 1st International Breast (Implant–) Conference 2009
2010 · F Stöblen, M Rezai, et al. · RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren
Simultane Studie über Docetaxel-basierte anthrazyklinfreie adjuvante Therapie sowie über Lebensstilintervention Success C
2009 · J Salmen, H Sommer, et al. · Senologie - Zeitschrift für Mammadiagnostik und -therapie
Toxicity analysis of a phase III study evaluating FEC-Doc vs. FEC-Doc in combination with gemcitabine as adjuvant treatment for breast cancer – the SUCCESS-trial.
2009 · BK Rack, W Janni, et al. · Cancer Research
Die SUCCESS-Studie – Toxizitätsanalyse einer Phase III Studie mit Docetaxel und Gemcitabine in der adjuvanten Therapie des frühen Mammakarzinoms
2008 · EM Genss, W Janni, et al. · Senologie - Zeitschrift für Mammadiagnostik und -therapie
Benchmarking as an instrument in the quality management in the treatment of breast cancer in Germany from 2003 to 2006
2008 · M. K. Graeser, R. Wuerstlein, et al. · Journal of Clinical Oncology
Nachweis zirkulierender Tumorzellen (CTC) im peripheren Blut von Patientinnen mit primärem Mammakarzinom
2007 · B Rack, C Schindlbeck, et al. · Senologie - Zeitschrift für Mammadiagnostik und -therapie
Works count: 21
Citation count: 108
H-index: 4
I10-index: 3
Year
Topic
Type